-
Mashup Score: 0FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials - The Cancer Letter - 3 hour(s) ago
The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the inclusion of tissue biopsies in clinical trials. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0David Chung named director of clinical research at Northwell Health - The Cancer Letter - 4 hour(s) ago
Northwell Health appointed David J. Chung, a prominent oncologist-investigator, as director of clinical research at the Northwell Health Cancer Institute. In this newly created role, Chung also will serve as system chief of multiple myeloma across Northwell’s cancer centers. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
David Chung named director of clinical research at @NorthwellHealth. https://t.co/WzRcTTkU3u https://t.co/cT94WRxPpC
-
-
Mashup Score: 1NCCN publishes patient resource on genetic testing to guide patient decisionmaking - The Cancer Letter - 5 hour(s) ago
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. The document provides guidance on testing for inherited genetic mutations that can raise the risk of cancer. To access this subscriber-only content please log in or subscribe.If your institution has a […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
.@NCCN publishes patient resource on genetic testing to guide patient decisionmaking https://t.co/kmqDDHj1cQ https://t.co/1SmF2ibLXj
-
-
Mashup Score: 1
FDA issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco products minimally or nonaddictive by limiting the level of nicotine in those products. If finalized, the United States would be the first country globally to take such a bold, life-saving action to prevent and reduce smoking-related disease and death. […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
FDA issues proposed rule to limit nicotine in cigarettes. https://t.co/cQDsR4RsUF https://t.co/ekGLdqH1Sn
-
-
Mashup Score: 4ACS report: Cancer mortality continues to drop despite rising incidence in women - The Cancer Letter - 7 hour(s) ago
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
.@AmericanCancer report: Cancer mortality continues to drop despite rising incidence in women https://t.co/Lrvh60Lh9J https://t.co/IGbuWUNsrx
-
-
Mashup Score: 12Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires - The Cancer Letter - 1 day(s) ago
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires, write @Dan_Theodorescu, Robert Figlin, @DrHowardSandler, and Joan August https://t.co/2cc2GWSym6 https://t.co/EjWQGxhPwh
-
-
Mashup Score: 2FDA approves acalabrutinib + bendamustine and rituximab for mantle cell lymphoma - The Cancer Letter - 1 day(s) ago
FDA approved acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell lymphoma who are ineligible for autologous hematopoietic stem cell transplantation. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
FDA approves acalabrutinib (@AstraZeneca) + bendamustine and rituximab for mantle cell lymphoma. https://t.co/UVZAzVCbc1
-
-
Mashup Score: 4ACS report: Cancer mortality continues to drop despite rising incidence in women - The Cancer Letter - 1 day(s) ago
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
.@AmericanCancer report: Cancer mortality continues to drop despite rising incidence in women https://t.co/Lrvh60Lh9J https://t.co/IGbuWUNsrx
-
-
Mashup Score: 0Trastuzumab emtansine improves OS in HER2+ breast cancer, phase III study shows - The Cancer Letter - 1 day(s) ago
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine, also referred to as T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared to trastuzumab alone, according to the final results of the phase III KATHERINE clinical trial led by researchers from the University […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
Trastuzumab emtansine improves OS in HER2+ breast cancer, phase III study (led by @pitt_medicine & @UPMCHillmanCC) shows. https://t.co/1sZ29z0kut
-
-
Mashup Score: 2FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials - The Cancer Letter - 1 day(s) ago
The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the inclusion of tissue biopsies in clinical trials. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet-
FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials. Guest editorial by @ASCO leaders. https://t.co/PDH6ErXtI3 https://t.co/0PPZgQKF7x
-
FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials. Guest editorial by @ASCO leaders. https://t.co/PDH6ErXtI3 https://t.co/0PPZgQKF7x